Zebra AC6074-095-20Recalls & reported problems
Q'Apel Medical LLC · The Neurovascular Access System Family consists of sterile, single-use catheters and accessories that are used together to facilitate the insertion and guidance of an appropriately sized interventional device into a selected vessel in the peripheral and neurovasculature. The Neurovascular Access System is comprised of the Neurovascular Access Catheter, Access Tool, Peel Away Introducer and Dilator. The Neurovascular Access System Family is offered in various lengths to accommodate physician preferences and anatomical variations. The distal end of the catheter is coated with hydrophilic coating to reduce friction during use and a radiopaque marker on the distal tip that is visible under fluoroscopy. · Class 2
All models of Zebra (8)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00857545008189), received between Mar 24, 2026 and May 21, 2026 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Break1
- Fracture1
Patient problems
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryMay 21, 2026Break
DURING AN MMA EMBOLIZATION PROCEDURE PERFORMED VIA FEMORAL ACCESS ON (B)(6) 2026, RESISTANCE WAS REPORTEDLY ENCOUNTERED BY THE PHYSICIAN DURING WITHDRAWAL OF A ZEBRA 6F 95 CM CATHETER WITHIN TORTUOUS ILIAC ANATOMY. THE PHYSICIAN REPORTED ASSOCIATED VESSEL SPASM, AFTER WHICH THE CATHETER REPORTEDLY KINKED, TWISTED, AND SEPARATED DURING REMOVAL ATTEMPTS. THE SEPARATED CATHETER SEGMENTS WERE REPORTEDLY RETRIEVED USING A SNARE, AND NO FRAGMENTS WERE REPORTED TO REMAIN IN THE PATIENT. THE PATIENT WAS REPORTED TO BE STABLE FOLLOWING RETRIEVAL OF THE CATHETER SEGMENTS. THE PRODUCT WAS RETURNED IN FOUR SHAFT SEGMENTS. EVALUATION IDENTIFIED MULTIPLE FRACTURE/SEPARATION LOCATIONS. THE COMBINED SEGMENT LENGTHS WERE CONSISTENT WITH THE MANUFACTURED DEVICE LENGTH SPECIFICATION, AND NO SIGNIFICANT ELONGATION WAS IDENTIFIED. VISUAL AND MICROSCOPIC EVALUATION IDENTIFIED TWISTING, FLATTENING, PINCHING, AND LOCALIZED COMPRESSION DAMAGE ACROSS MULTIPLE REGIONS OF THE CATHETER. THE FRACTURE MORPHOLOGY APPEARED TORN AND IRREGULAR, CONSISTENT WITH MECHANICAL STRESS DURING DEVICE REMOVAL AND RETRIEVAL. FEED GAP SPACING AND REINFORCEMENT PATTERN WERE OBSERVED TO BE UNIFORM THROUGHOUT THE EVALUATED REGIONS
Patient problems: Insufficient Information
MAUDE report 25239303 ↗MalfunctionMar 24, 2026Fracture
ON (B)(6), 2026, Q'APEL MEDICAL BECAME AWARE OF A REPORTED ZEBRA 6F 95 CM BERNSTEIN CATHETER FRACTURE THAT OCCURRED DURING A PIPELINE EMBOLIZATION PROCEDURE. THE DEVICE WAS INTRODUCED VIA A MERIT 22 CM 7F SHEATH AND ADVANCED TO THE HIGH PETROUS CAROTID THROUGH TORTUOUS ANATOMY, INCLUDING A 360-DEGREE CERVICAL CAROTID LOOP. THE CATHETER WAS INSPECTED PRIOR TO USE AND NO DEFECTS WERE OBSERVED. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITH NO REPORTED PATIENT INJURY. DURING WITHDRAWAL OF THE ZEBRA CATHETER THROUGH THE STATIONARY SHEATH, WHICH WAS NOT RETRACTED, RESISTANCE WAS ENCOUNTERED IN THE CERVICAL CAROTID REGION. THE PHYSICIAN REPORTED THAT THE CATHETER WAS NOT ROTATED, NO VASOSPASM OCCURRED, AND NO EXCESSIVE FORWARD PRESSURE WAS APPLIED. THE PHYSICIAN INDICATED THE MALFUNCTION LIKELY OCCURRED DURING WITHDRAWAL. FOLLOWING REMOVAL, A KINK WAS OBSERVED AND FLUID LEAKAGE WAS NOTED AT THE KINK SITE. NO MULTIPLE REPOSITIONING ATTEMPTS WERE REQUIRED, AND NO TIP MODIFICATION WAS PERFORMED. THE DEVICE WAS REMOVED FROM THE PATIENT AND NO ADDITIONAL INTERVENTION WAS REQUIRED. THE DEVICE WAS RETURNED TO THE MANUFACTURER FOR EVALUATION ON (B)(6), 2026. RETURNED PRODUCT ANALYSIS CONFIRMED A
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 24676979 ↗
Other Catheter, Percutaneous devices
- WATCHMAN FXD Curve™ Access System M635TU80020Boston Scientific Corporation · Catheter, percutaneous1 recall47 deaths654 reports
- NA C315HIS02Medtronic, Inc. · Catheter, percutaneous1 recall369 reports
- WATCHMAN TruSteer™ Access System M635TU90050Boston Scientific Corporation · Catheter, percutaneous1 recall28 deaths302 reports
- Guidezilla™ II H7493933515060Boston Scientific Corporation · CATHETER, PERCUTANEOUS1 recall3 deaths278 reports
- Velocity Delivery Microcatheter VEL160STR-APenumbra, Inc. · CATHETER, PERCUTANEOUS297 reports
- Guidezilla™ H7493924215050Boston Scientific Corporation · CATHETER, PERCUTANEOUS294 reports
- WATCHMAN™ TruSeal™ Access System M635TU70020Boston Scientific Corporation · Catheter, percutaneous1 recall11 deaths217 reports
- Lantern Delivery Catheter PXSLIMLAN135T45Penumbra, Inc. · CATHETER, PERCUTANEOUS220 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page